Management of Drug-Induced Neutropenia in Recurrent Pneumonia

Diagnostic Approach

The American College of Physicians recommends obtaining a complete blood count with manual differential to assess absolute neutrophil count (ANC) and band forms, which is essential for infection risk stratification 1
The Infectious Diseases Society of America suggests that band forms and left shift (≥6% bands or ≥1,500 bands/mm³) indicate bacterial infection, and this assessment is critical for guiding antibiotic therapy 1, 2

The American Thoracic Society states that neutropenia (WBC <4,000/mm³) in pneumonia is associated with a high risk of severe bacterial infection and sepsis, and profound neutropenia (ANC <500/mm³) requires consideration of growth factor support 3

The American College of Chest Physicians recommends switching to a completely different antibiotic class if suspected recurrent pneumonia, such as switching from beta-lactam to respiratory fluoroquinolone (levofloxacin or moxifloxacin) 4
The National Comprehensive Cancer Network suggests considering G-CSF (filgrastim) if ANC <500/mm³ with clinical signs of infection, patient shows clinical deterioration despite antibiotic change, or fever persists with profound neutropenia 3

The Centers for Disease Control and Prevention recommend daily CBC with manual differential until WBC >4,000/mm³, and daily temperature monitoring to assess for clinical response 1, 4
The Society of Critical Care Medicine suggests monitoring pulse oximetry and respiratory rate assessment, as well as clinical assessment for new infection sources (urinary symptoms, skin changes, diarrhea) 6, 1